TFFP (tffpharma.com) Volume dodolan mangsa ngarep perusahaan

Logo perusahaan publik TFF Pharmaceuticals Inc. (TFFP)

The B2B platform expansion of TFF Pharmaceuticals (TFFP) for the creation of inhalation powders provides a hedge against geopolitical risks, confirming the company's future sales volume. The 0.00 mark characterizes this parameter, demonstrating operational resilience. Completing the picture are patents for vaccine micronization, which guarantee stable royalties from pharmaceutical behemoths for the use of this unique delivery technology.

TFFP - Pendapatan sing dikarepake perusahaan TFF Pharmaceuticals, Inc ing rentang 04.07.2022 - 21.12.2024

Rincian metrik keuangan lan pasar TFF Pharmaceuticals, Inc (TFFP)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:TFF Pharmaceuticals, Inc.
Sampel barang TFF Pharma

This indicator forecasts future cash flows from sales by assessing market expectations rather than historical data. For TFF Pharmaceuticals (TFFP), the organization's prospective sales reflect a critical decline due to the loss of human capital and the cessation of development. The drop in this line confirms the actual liquidation of the company's operating activities. Investors should view such a trend as a signal to exit the asset. The business possesses no fundamental stability.

Pesaing langsung

Prakiraan volume dodolan HLN|KVUE (Kenvue Inc) - Pendapatan mangsa ngarep perusahaan|Verona Pharma Corp - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan MENS (Jyong Biotech Ltd)|ligand.com - Prakiraan volume dodolan|amneal.com (AMRX) - Volume dodolan mangsa ngarep perusahaan|Perrigo (PRGO) - Prakiraan pendapatan perusahaan|ALVO (Alvotech S.A.) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan LQDA|Prakiraan volume dodolan Galapagos Corp|Prakiraan pendapatan perusahaan ANI Pharma (ANIP)|Prakiraan volume dodolan MannKind Corporation (MNKD)|Prakiraan pendapatan perusahaan Amphastar Pharmaceuticals Inc AMPH|Prakiraan volume dodolan Pacira PCRX|ARS Pharmaceuticals Inc - Prakiraan volume dodolan|TBPH - Prakiraan volume dodolan|AQST (Aquestive Therapeutics) - Volume dodolan mangsa ngarep perusahaan|scPharmaceuticals, Inc. (SCPH) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan TECX|Prakiraan volume dodolan Tonix Pharma|Volume dodolan mangsa ngarep perusahaan SXTC (SXT Pharmaceuticals)|EPRX: Pendapatan sing dikarepake perusahaan|BioHarvest Sciences - Volume dodolan mangsa ngarep perusahaan|EXOZ: Prakiraan pendapatan perusahaan|ORMP - Prakiraan pendapatan perusahaan|ENTX: Prakiraan pendapatan perusahaan|HYFT: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan ABVC BioPharma Inc|CPIX (Cumberland Corp) - Prakiraan volume dodolan|Prakiraan volume dodolan quantumbiopharma.com|Prakiraan volume dodolan FGEN|Volume dodolan mangsa ngarep perusahaan Telomir Pharmaceuticals, Inc. TELO|Prakiraan volume dodolan RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Pendapatan sing dikarepake perusahaan|RLYB: Volume dodolan mangsa ngarep perusahaan|lexariabioscience.com (LEXX) - Volume dodolan mangsa ngarep perusahaan|Pulmatrix Inc (PULM) - Prakiraan pendapatan perusahaan|PTHL: Prakiraan volume pendapatan perusahaan|APM (Aptorum Group Ltd) - Prakiraan volume dodolan|Lyra Therapeutics Inc (LYRA) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan IBO|Prakiraan volume pendapatan perusahaan TNFA|cbdMD, Inc. - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan PRFX|Altamira Therapeutics Ltd. - Prakiraan volume dodolan|LIPO: Prakiraan pendapatan perusahaan|OPTN: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - Prakiraan volume dodolan|PTPI (Petros Pharmaceuticals Inc) - Prakiraan volume pendapatan perusahaan|Prakiraan volume dodolan QLI|SLRN - Volume dodolan sing dikarepake perusahaan